Invasive breast cancer cells have the ability to extend membrane protrusions, invadopodia, into the extracellular matrix (ECM). These structures are associated with sites of active matrix degradation. The amount of matrix degradation associated with the activity of these membrane protrusions has been shown to directly correlate with invasive potential. We demonstrate here that microinjection of polyclonal anti-cortactin antibodies blocks matrix degradation at invadopodia supporting the hypothesis that cortactin has a direct role in invasive behavior. MDA-MB-231, invasive breast cancer cells were sheared from the surface of a gelatin matrix to isolate invadopodia. Cortactin, paxillin and protein kinase C (PKC) m, a serine kinase, were co-immunoprecipitated as a complex from invadopodia-enriched membranes. We con®rmed the subcellular distribution of these proteins by immunolocalization and Western blotting. We also determined that, in contrast to its presence in invasive cells, this complex of proteins was not detected in lysates from non-invasive cells that do not form invadopodia. Taken together, these data suggest that the formation of this cortactin-containing complex correlates with cellular invasiveness. We hypothesize that this complex of molecules has a role in the formation and function of invadopodia during cellular invasion.
Introduction
When invasive cells such as Rous sarcoma virustransformed chicken embryo ®broblasts or metastatic cancer cell lines are cultured on ECM, actin-containing protrusions, called invadopodia, extend into the matrix and participate in matrix degradation (Chen, 1989; Coopman et al., 1996; Monsky et al., 1994; Mueller and Chen, 1991) . There is a correlation between the ability of cells to locally degrade the matrix at invadopodia, and their invasive potential as measured in other in vitro and in vivo assays for motility and invasion (Coopman et al., 1998) . Membrane-associated proteases including seprase, membrane type-1 matrix metalloproteinase, and matrix metalloproteinase-2 are thought to mediate ECM degradation at sites of invadopodial extension (Nakahara et al., 1996 (Nakahara et al., , 1997 Monsky et al., 1993 Monsky et al., , 1994 . Actin and actin-associated molecules such as a-actinin, talin, tensin and paxillin concentrate in or around invadopodia (Mueller et al., 1992; Chen, 1989) .
A number of lines of evidence suggest that cortactin may have an important role in modulating invasive cell behavior. Cortactin binds to F-actin in vitro, colocalizes with cortical actin at ruing membranes, and possesses actin-bundling activity that is modulated by c-Src, suggesting a role in membrane motility (Wu and Parsons, 1993; Huang et al., 1997) . In v-Srcactivated ®broblasts transformed by Rous sarcoma virus, cell motility and invasiveness are increased, cortactin becomes phosphorylated on tyrosine residues enabling an association with v-Src in podosomes (Okamura and Resh, 1995) . Overexpression of cortactin in NIH3T3 ®broblasts or endothelial cells increases cell motility in vitro (Patel et al., 1998; Huang et al., 1998) . Cortactin overexpression has also been implicated in breast cancer progression. The human homologue of the cortactin gene, EMS1 (Schuuring et al., 1992) is overexpressed in a number of breast cancer cell lines (Schuuring et al., 1993; Campbell et al., 1996) . In human breast carcinoma, the majority of tumors showing an 11q13 overampli®cation, also show an increase in expression of cortactin, and this has been correlated with poor patient prognosis (Schuuring et al., 1992) . In cells with this ampli®cation, cortactin has been shown to redistribute to contact sites at the margins of cells, concurrent with an increase in its levels of phosphorylation (van Damme et al., 1997) . In untransformed cells, cortactin is a downstream target for tyrosine phosphorylation following cell adhesion to ®bronectin (Vuori and Ruoslahti, 1995) . As a consequence of this, it has been suggested that cortactin also may have a role in the regulation and remodeling of the cytoskeleton in response to speci®c extracellular stimuli (Vuori and Ruoslahti, 1995) .
Paxillin, a focal adhesion protein (Turner et al., 1990) , is phosphorylated in response to integrinmediated adhesion (Burridge et al., 1992) . V-Src transformation causes a partial redistribution of paxillin from focal adhesions to invadopodia in Rous sarcoma virus-transformed chicken embryo ®broblasts grown on a gelatin matrix (Mueller et al., 1992) . Viral transformation also causes a signi®cant increase of both paxillin expression and tyrosine phosphorylation in invasive and metastatic cervical tumors (McCormick et al., 1997) . Since tyrosine phosphorylation of paxillin increases in response to migratory stimuli, a direct role in motility has been suggested (Abedi et al., 1995) . However, the functional role of paxillin both in transformed and normal cell types remains largely unidenti®ed.
Another downstream response to integrin-mediated adhesion includes activation of PKC. PKC activity is involved in integrin-mediated responses including adhesion, motility and membrane ruing (Lewis et al., 1996; Klemke et al., 1994; Yebra et al., 1995; Miyata et al., 1989) . It can also aect invasive behavior (Ways et al., 1995) . PKC activation has been demonstrated as a controlling factor in the reabsorbtion activity exhibited by osteoclasts, a non-transformed cell type, responsible for bone remodeling (Moonga et al., 1996) . PKC activity is also implicated in certain breast cancers where expression is higher in tumors compared with normal tissue (O'Brian and Ward, 1989) .
In this report, we describe that in invasive human breast cancer cells, cortactin, paxillin and the PKC isoform PKCm, are associated as an invasion-related complex in invadopodia. We describe a correlation between formation of this complex of molecules and the invasive phenotype in breast cancer cells. These data identify a novel invadopodia associated distribution for both cortactin and PKCm. We con®rm the colocalization of cortactin, paxillin and PKCm at invadopodia by immuno¯uorescence. We report that microinjection of the anti-cortactin poyclonal antibody (pAb) disrupts invadopodia function, blocking the matrix degradation associated with these structures. This suggests that cortactin has a direct role in the coordination of local invasion mediated by the formation of invadopodia. The interaction of cortactin with paxillin and PKCm at invadopodia suggests that these molecules have a direct role in the regulation of invadopodia activity.
Results

Invasive breast cancer cells extend invadopodia into the matrix
Ultrathin vertical sections of MDA-MB-231 cells grown on crosslinked gelatin beads were examined by transmission electron microscopy. Invasive breast cancer cells extend long protrusions, or invadopodia, into the surface of the bead from their ventral membrane surface (Figure 1a and b, arrows). The region of interest examined in the electron micrograph ( Figure 1b) is highlighted in the schematic diagram ( Figure 1a , shaded box). Frequently, there are clear areas around the extending protrusions where invadopodia-associated proteolytic activity presumably has perturbed the crosslinked gelatin bead. Invasion is often concentrated in an area at the ventral membrane under or near the nucleus.
Microinjection of anti-cortactin pAbs blocks local invasion
To test the hypothesis that cortactin is required for the invasive function of invadopodia, MDA-MB-231 cells were cultured on¯uorescein isothiocyanate (FITC)-crosslinked gelatin matrices. Cells were microinjected with either preimmune IgG or the anti-cortactin pAb (#170-10). As previously described, these cells locally degrade an FITC matrix to leave dark areas, easily detectable by immuno¯uorescence microscopy (Coopman et al., 1996) . We have demonstrated previously that the in vitro invasive behavior of cells grown on gelatin and measured by phagocytosis is similar to their behavior in this assay when grown on collagen I and Matrigel (Coopman et al., 1998) . We have also demonstrated that transformed cells will make invadopodia on a range of ECM substrates including ®bronectin, collagen type I, collagen type IV and laminin . We use crosslinked gelatin in our in vitro assays because it is easily handled and because in these assays, it allows a rapid and visual dierentiation between non-invasive and invasive cells.
Initially, we cultured cells in the absence of serum in order to block matrix degradation prior to microinjection. Following a period of recovery after microinjection, serum free culture media was replaced with serum containing media. This released the serum dependant block in matrix degradation and the cells were allowed to invade into the ®lms for 5 h. Microinjected antibody was visualized using Texas red conjugated anti-rabbit secondary antibody and nuclei were visualized by coinjected 4,6-diamidino-2-phenylindole (DAPI). Microinjection with the preimmune IgG did not signi®cantly inhibit matrix degradation (Figure 2 , preimmune). Microinjection of the anti-cortactin pAb (#170-10) signi®cantly inhibited hole formation (Figure 2 , Immune versus preimmune cells, P=0.006). An examination by both phase contrast and immunofluorescence microscopy revealed that microinjected cells remained well spread and that there were no signi®cant morphological changes. Therefore, we conclude that cortactin function is required for either the formation and/or function of invadopodia as measured by matrix degradation.
An immunoprecipitable complex of cortactin, paxillin and PKCm
To identify the components of MDA-MB-231 invadopodia that interact with cortactin, we isolated invadopodia-enriched subcellular fractions. Cell bodies were sheared away from the surface of a crosslinked gelatin matrix to obtain a fraction enriched in invadopodia (INV) (Mueller et al., 1992) . The cell bodies were further fractionated by centrifugation to yield two fractions, one containing the cell body membranes (CBM) and the other the cytosol (CYT). b1 integrin localized predominantly to the CBM and INV membane containing fractions, demonstrating an ecient separation of membranes and cytosol ( Figure  3a , b1 integrin: CBM and INV). The presence of b1 integrin in the INV fraction is consistent with a previously described localization to invadopodia (Mueller et al., 1992; Coopman et al., 1996) .
We used immuno¯uorescence to visualize structures associated with the gelatin after shearing (Figure 3b ). Phalloidin staining of F-actin revealed clusters of punctate structures in association with the gelatin (Figure 3b , solid arrows). There were, however, few if any, streak like structures. Staining with an antivinculin antibody that recognizes focal adhesions demonstrated that there was no vinculin staining material associated with the gelatin matrix suggesting that focal adhesions have been removed from the surface of the gelatin (data not shown). This is consistent with immunoblotting experiments in which focal adhesion kinase (FAK) was detected in the CBM but not the INV fraction and suggests that focal adhesions have been scraped away from the surface of the gelatin (data not shown).
We performed immunoprecipitation experiments from each of the fractions in order to identify molecules that interact with cortactin. Cortactin immunoprecipitations and supernatants were examined by Western blot analysis. Cortactin was immunoprecipitated eciently from each of the fractions, CBM, INV, and CYT, leaving only trace amounts detected in the supernatant from the immunoprecipitation (Figure 3c We also examined a time course of cells fractionated at 6, 24 and 48 h on gelatin ( Figure 3d ). We wanted to determine if there was any shift in the localization of the complex over time and with increasing cell density. Again, we performed cortactin immunoprecipitations from each fraction at each time point and analysed the results by SDS ± PAGE and Western blotting. Initially, we examined the immunoprecipitation of cortactin to determine the level of immunoprecipitation from each fraction ( Figure 3d , Cortactin Blot, 6, 24 and 48 h: CBM, INV and CBM). The Western blots were then stripped and reprobed for paxillin and PKCm. Coimmunoprecipitation was evident between cortactin, paxillin and PKCm in the INV fraction ( Figure 3d , Paxillin and PKCm Reblots, 6, 24 and 48 h: INV). However, although there was co-immunoprecipitation at 6 and 24 h in the CYT fraction, the interaction was no longer detected at 48 h although cortactin was present in this fraction ( Figure 3d , Paxillin and PKCm Reblots, 6, 24 and 48 h: CYT, Cortactin Blot, 48 h: CYT).
We also wanted to explore the possibility that there was a correlation between an invasive phenotype and formation of the complex. We examined both invasive and non-invasive breast cancer cell lines for the presence of the complex. Non-invasive breast cancer cell lines form few or no invadopodia compared with invasive breast cancer cell lines ( The invasion assay data of`Cell Outgrowth in Matrigel',`Behaviour in Nude Mice',`Chemoinvasion', and`Chemotaxis' of breast cancer cells are from a previous study (Thompson et al., 1992) .
b The invasion assay data of`Film Degradation' is from Coopman et al. (1998) . c   Table  abbreviations include: Sph, spherical colony/non-invasive cluster formation in Matrigel; Inv, invasive colony formation; P, primary tumor only; N, non-tumorigenic; Li, local invasion; HM, hematogenous metastases to lungs. The chemoinvasive and chemotaxis assays are all graded in terms of a percentage of the measured activity of MDA-MB-231 cells, i.e., +, 0 ± 20%; ++, 20 ± 40%; +++, 40 ± 60%; ++++, 60 ± 80% and +++++, 80 ± 100%. The ®lm degradation assay is graded in terms of a percentage of the highest measured activity; +, 0 ± 20%; ++, 20 ± 40%; +++, 40 ± 60%; ++++, 60 ± 80%; +++++, 80 ± 100%
al., 1998). Paxillin immunoprecipitates from total cell lysate of cell lines grown on tissue culture treated plastic were analysed by SDS ± PAGE and Western blotting (Figure 4a ). The Western blot was ®rst probed for paxillin to establish the level of paxillin that was immunoprecipitated from lysates of the cell lines examined (Figure 4a , Paxillin Blot). Cortactin and PKCm co-immunoprecipitated with paxillin from the whole cell lysates of only those cell lines characterized as having a more motile and invasive nature, MCF-7-ADR, MDA-MB-231, and HS578T (Figure 4a , Cortactin and PKCm Reblots and Table 1 ) (Thompson et al., 1992) . Vinculin, FAK, PKCa and PKCd did not co-immunoprecipitate with paxillin under these conditions (data not shown). We examined the expression levels of each of the proteins screened for co-immunoprecipitation with paxillin. In every case, there was easily detectable expression of each protein (Figure 4b ). Thus, we conclude that co-immunoprecipitation of cortactin and PKCm with paxillin does not correlate with the expression levels of these proteins in breast carcinoma cell lines, but rather with their invasive and/or motile behavior. Since the complex was isolated from cells grown on plastic, we also conclude that the cells do not require exogenous ECM to generate the complex.
Cortactin, paxillin and PKCm co-localize at invadopodia by immuno¯uorescence
To con®rm the co-distribution of cortactin with paxillin and PKCm at invadopodia, we immunolocalized these molecules in intact cells cultured on crosslinked gelatin. Cortactin localized with F-actin, identifying invadopodia as punctate sites of labeling (Figure 5a and b, solid arrows) . This puntcate staining represents short protrusions that extend into the gelatin matrix beneath the cells perpendicular to the plane of view (Figure 5a , cortactin (red) and Figure 5b , cortactin colocalizing with actin (yellow)). We con®rmed this using confocal microscopy (data not shown). Cortactin also colocalized with actin at ruing membranes (Figure 5a and b, arrowhead) , whereas it did not colocalize with actin stress ®bers.
To verify that the membrane protrusions identi®ed by labeling with cortactin were associated with ECM degrading activity, we utilized an immuno¯uorescent assay that demonstrates membrane-associated degradation. When MDA-MB-231 cells are cultured on crosslinked FITC-gelatin, the cells produce dark holes of degradation against a background of bright uorescent matrix. We used two-color¯uorescence microscopy to visualize either the FITC-gelatin matrix ( Figure 5c , e and f) or cortactin localization (Figure 5d , e and f). Anti-cortactin monoclonal antibodies (mAbs) localized cortactin to ruing membranes (Figure 5d , arrowhead) and areas of punctate staining (Figure 5d , solid arrow). The sites of punctate cortactin staining co-localized with sites of invasion identifying these structures as invadopodia (Figure 5e and f, solid arrows). Image analysis was used to detect cortactin and this overlay image, outlining cortactin staining, was merged with the two-color image to visualize the areas of overlap (Figure 5f ). We also performed double labeling experiments with antibodies against cortactin and paxillin on cells plated onto crosslinked gelatin. Paxillin localized to focal adhesions (Figure 5g , open arrow) as well as punctate sites where it colocalized with cortactin ( Figure 5g and g', closed arrows) . PKCm has previously been described as a Golgi localized protein (Prestle et al., 1996) . The association of PKCm with cortactin and paxillin in the INV fraction indicates a novel plasma membrane localization. We con®rmed this previously unreported localization for PKCm by immuno¯uorescence. First, we examined the immuno¯uorescence localization of PKCm using a number of commercially available mAbs and pAbs. Anti-PKCm mAb (clone P26720) produced a perinuclear, Golgi-like staining (Figure 5h , solid arrow) consistent with the Golgi associated localization previously reported in the literature (Prestle et al., 1996) . However, using two commercially available pAbs, we observed staining of the cell membrane, particularly at rues (Figure 5i , arrowhead), as well as a perinuclear staining (Figure 5i , closed arrow). Staining, however, was particularly sensitive to detergent extraction. We con®rmed the speci®city of one of the pAbs using a synthetic peptide antigen to block speci®c binding. The peptide eliminated the staining of both the Golgi and plasma membrane components, con®rming the speci®city of the antibody for PKCm (data not shown).
The extensive membrane staining and Golgi localization of PKCm rendered it extremely dicult to observe immuno¯uorescent staining at invadopodia. However, we were able to detect the presence of PKCm in invadopodia after shearing away cell bodies. We ®xed cells in formaldehyde and then scraped the cell bodies from the surface of the FITC-gelatin matrix. After a brief Triton X-100 extraction, the remaining cellular material was immunostained with anti-PKCm antibodies. This process is in contrast to the cell fractionation protocol where there was no ®xation before shearing the cells. Fixation leaves rues ( Figure  5j , arrowhead) and invadopodia ( Figure 5j , solid arrows) in contact with the matrix. Using this technique we con®rmed that PKCm staining colocalized with sites of matrix degradation (Figure 5j , solid arrows).
Discussion
In the present study, we demonstrate by immunofluorescence, cell fractionation and Western blotting that cortactin, paxillin, and PKCm form a novel complex associated with invadopodial membranes that extend into a crosslinked matrix. Its presence in both invasive cell lines and its association with subcellular protrusions at sites of matrix degradation suggest that the formation and membrane association of this complex contribute to the invasive phenotype of these cells.The inhibition of localized matrix degradation following microinjection of anti-cortactin antibodies supports the hypothesis that cortactin, in particular, plays a major role in mediating cellular invasion. Cortactin is an actin-bundling protein (Huang et al., 1997) . Therefore, one role of cortactin might be to participate in ®lopodia formation by bundling actin. Alternatively, since cell surface associated proteases mediate matrix degradation, an association of cortactin with the membrane, as a component of the complex, may participate in the localization of matrix degrading proteases to invadopodia. Our working model illustrates these two potential mechanisms leading to the formation of an active invadopodium ( Figure 6 ). Our data currently cannot distinguish between these possibilities.
The speci®c function of cortactin in invadopodia may be modulated by its interactions with paxillin and the protein serine kinase, PKCm. The invasion-related complex of cortactin/paxillin/PKCm was isolated from invadopodia-enriched fractions and was not present at signi®cant levels in the CBM fraction although the component molecules were present. Since all three proteins, cortactin, paxillin, and PKCm also localize to invadopodia using immuno¯uorescence microscopy, we conclude that the complex is localized to the membranes of invadopodia. Using a variety of Figure 5 Immuno¯uorescent localization of actin, cortactin, paxillin and PKCm at invadopodia. MDA-MB-231 cells were cultured on FITC labeled or unlabeled gelatin ®lms coated onto glass coverslips. Primary antibodies were detected using either Texas red (red) or FITC (green) secondary antibodies. Actin was detected using FITC-phalloidin (green) and nuclei were detected using DAPI (blue). Images were collected by conventional wide ®eld¯uorescence microscopy (a ± f, h ± j) or confocal microscopy (g). (a ± f) Actin and cortactin co-localized in invadopodia. Cells grown on a glass coverslip were probed with anti-PKCm polyclonal D20. This staining was representative of that seen using either the D20 or N20 anti-PKCm pAbs and showed ruing membranes (arrowhead) and bright perinuclear staining (closed arrow). (h and i) Scale bar=10 mm. (j) Fixed cells were sheared from the surface of the FITC gelatin matrix as described in Materials and methods. Punctate sites of invadopodia labeled with PKCm pAbs (red) and co-localized with areas of degradation (closed arrows). Scale bar=5 mm techniques we established that focal adhesions and focal adhesion associated proteins including FAK and vinculin, are not present in our invadopodia enriched fractions. We were somewhat surprised that FAK failed to associate with the complex of proteins at invadopodia as FAK binds to paxillin (Hildebrand et al., 1995; Tachibana et al., 1995) . However, although we did detect the co-association of paxillin and FAK following immunoprecipitation of paxillin from the CBM fraction, we did not detect this association in the INV fraction (data not shown). We conclude that FAK and FAK-paxillin complexes are not prominent components of invadopodia. In summary, our data suggest that FAK associates with paxillin in focal adhesions but not in invadopodia. Paxillin may therefore engage in dierential signaling pathways based upon its subcellular localization. We hypothesize that the association of paxillin with cortactin in invadopodia in¯uences a downstream signaling pathway that is related to invasion and matrix degradation.
All three proteins from the complex localized to the CYT fraction, and the complex could also be immunoprecipitated from this fraction. Isolation of the complex from the cytosol might simply re¯ect a release from the membrane during the fractionation procedure. Alternatively, it is possible that the complex is in equilibrium between the cytosol and membrane. It is unlikely that the complex detected in the INV fraction represents complex formed in the cytosol that non-speci®cally sticks to the INV membranes. In support of this interpretation, the time course of distribution of the complex between the fractions demonstrated that there is no longer any complex associated with the CYT fraction at 48 h although it is present in the INV fraction. Previously, we and others, have demonstrated that with increasing time and cell density, there is a decrease in invasive behavior in vitro (Coopman et al., 1998; Tamaki et al., 1996; Xie et al., 1994) . The absence of the complex from the CYT at 48 h suggests that the association of the complex with the invadopodia fraction is speci®c and supports our theory that the association of the complex with the CYT fraction is more transitory in nature. The loss of the complex in the CYT fraction therefore correlates with a decrease in invasive capacity suggesting that the cytosolic pool of the complex may be depleted.
The role of the protein serine kinase PKCm in metastatic breast disease is unknown. However, several PKC isoforms have been directly implicated in the aggressive behavior of a number of tumor types, including PKCa in glioblastoma cells, where antisense oligonucleotide therapy inhibited tumor growth (Yazaki et al., 1996) . The presence of PKCm in these complexes was initially puzzling given its previously reported localization to the Golgi (Prestle et al., 1996) . However, the association of PKCm with invadopodialocalized complexes was demonstrated by co-immunoprecipitation with paxillin and cortactin from lysates of invasive cell lines and from invadopodia-enriched membrane fractions. This association was speci®c, other PKC isoforms including PKCa and PKCd were not co-immunoprecipitated. We found that the immuno¯uorescence localization of PKCm at invadopodia was dicult to detect because of sensitivity to detergent extraction. However, our results suggest that polyclonal antibodies directed against PKCm, more sensitively detect other sites of subcellular localization including a punctate staining at the plasma membrane. Even under optimized ®xation conditions, the monoclonal anti-PKCm antibody failed to recognize membrane and cytosolic PKCm. We speculate that the role of PKCm in invadopodia may be as a regulator of invasive function via speci®c serine phosphorylation events. Thus, one role of PKCm may be to modulate either complex formation or activity at invadopodia.
Finally, to reiterate, our data support the conclusion that the formation of a complex comprising cortactin, paxillin and PKCm is associated with the invasive phenotype of breast cancer cells and that cortactin is required for invadopodia mediated matrix degradation. We suggest that the activity of this complex may be to coordinate the aggregation and/or activation of matrix Figure 6 A model for the role of the cortactin-containing complex in the formation of invadopodia. The formation of an active invadopodium involves a coordination of cytoskeletal rearrangements to form a membrane protrusion and the localization and activation of ECM-degrading proteases at this protruding membrane. Two possible sequences of events are illustrated. The cortactin-containing complex may ®rst bind to the membrane, coupling the actin cytoskeleton to the membrane to generate a membrane protrusion. The protease becomes linked to the assembling membrane protrusion by interaction with a transmembrane protein, e.g. an integrin or activating transmembrane protease. Alternatively, the complex may associate with the membrane protein ®rst and this complex might recruit ECMdegrading proteases. Then, the coupling of the actin cytoskeleton to this complex would activate clustering of the complexes at sites of membrane protrusion degrading proteases together with cytoskeletal rearrangements at forming invadopodia. Protein kinase activity may regulate multiple steps during this process that results in the formation of matrix degrading competent invadopodia. These points of regulation remain to be elucidated and will be the subject of further studies.
Materials and methods
Cell culture
All cell lines were obtained from the Lombardi Cancer Center Tissue Culture Shared Resource and originated from the American Type Culture Collection (ATCC, Rockville, MD, USA). Cells were maintained in Falcon¯asks (Becton and Dickinson Labware, Plymouth, UK) in a 1 : 1 mixture of RPMI 1640 : DMEM (Mediatech, Washington, DC, USA) supplemented with 10% bovine calf serum (Hyclone Laboratories Inc., Logan, Utah, USA) and 5% NU-serum (Becton Dickinson Labware, Franklin Lakes, NJ, USA) and 2 mM L-glutamine (Gibco BRL, Gaithersburg, MD, USA). Cells were grown in the presence of 7.5% CO 2 and passaged regularly to avoid post-con¯uent growth. Cells were examined regularly for the presence of Mycoplasma contamination.
Antibodies
Mouse anti-cortactin mAbs (clone 4F11) were generously provided by Dr T Parsons (Department Of Microbiology, University of Virginia, Charlottesville, VA, USA) or were obtained from Upstate Biotechnology (Lake Placid, NY, USA). Polyclonal antibodies (pAb) to chicken cortactin were prepared by injecting a glutathione S-transferase (GST)-cortactin fusion protein into rabbits. The constructs used to generate GST-cortactin were also the kind gift of Dr Tom Parsons. Fusion proteins were bacterially expressed and IgG was puri®ed from both immune and preimmune rabbit sera using Protein A chromatography (Pierce, Rockford, IL, USA). Anti-GST antibodies were removed from both preparations by anity chromatography using GST-Sepharose as described by the manufacturer (Pierce). We veri®ed that the anti-cortactin pAb (#170-10) recognized the same protein as the anti-cortactin mAb (4F11) by immunoprecipitation and immuno¯uorescence experiments. Cortactin, immunoprecipitated by the mAb (4F11) was Western blotted using either the pAb (#170-10) or the mAb (4F11). Both of these antibodies recognized protein bands at p80/p85, corresponding to the molecular weight of cortactin (data not shown). The anti-cortactin pAb (#170-10) also immunostained invadopodia, co-localizing with immunostaining of the anti-cortactin mAb (4F11) in double labeling experiments (data not shown).
The mouse anti-paxillin (clone 349), anti-FAK (clone 2A7) and anti-PKCm (clone P26720) mAbs were from Transduction Laboratories (Lexington, KY, USA). The rat anti-b1 integrin antibody (mAb 13) was a kind gift from Dr Steven Akiyama (National Institute of Environmental Health Science). Mouse anti-phosphotyrosine (clone 4G10) and anti-vinculin mAbs were from Upstate Biotechnology. Rabbit D20, C20 and N20 anti-PKCm polyclonal antibodies (pAb) were from Santa Cruz Biotechnology, Inc., (Santa Cruz, CA, USA). D20 epitope binding-site blocking peptide was also from Santa Cruz Biotechnology, Inc. We determined that the anti-PKCm mAb recognized the same antigen as the pAbs D20, C20 and N20 by immunoprecipitation and Western blotting. PKCm, immunoprecipitated by the mAb (P26720) was Western blotted using either the pAbs or the mAb (P26720). All of these antibodies recognized a protein band at p115, corresponding to the molecular weight of PKCm (data not shown). Fluorescently labeled and unlabeled, anity puri®ed anti-mouse and anti-rat IgG+IgM secondary antibodies were from Jackson Laboratories (West Grove, PA, USA) and HRP-conjugated secondary antibodies were from Rockland (Gilbertsville, PA, USA).
Transmission electron microscopy
Cells (5610 5 /ml) in complete culture medium were incubated overnight with approximately 2610 6 large (4100 mm) gelatin beads at 378C. The mixture was rotated continuously, endover-end, to promote the even attachment and spreading of cells on the surface of the beads. The pellet of gelatin beads coated with cells was ®xed with 2% glutaraldehyde/3% paraformaldehyde in PBS (150 mM NaCl, 1.9 mM NaH 2 HPO 4 , pH 7.2) for 2 h. Post-®xation was in 1% osmium tetroxide in distilled water for 1 h before processing for conventional ultrathin section electron microscopy as previously described (Coopman et al., 1996) . Sections were post-stained with uranyl acetate and lead citrate and photographed with a JEOL 1200EX-transmission electron microscope operated at 60 kV.
Microinjection
MDA-MB-231 cells were seeded onto Eppendorf grided coverslips in serum-free media (Fisher, Rockville, MD, USA) previously coated with FITC-crosslinked gelatin ®lms. After culture overnight at 378C in a CO 2 incubator, cells were microinjected using the Eppendorf microinjection system (Fisher) with either puri®ed preimmune IgG or the anti-cortactin IgG (#170-10) at 1 mg/ml, mixed 1 : 1 with 40 mg/ml DAPI in sterile PBS. Coverslips were returned to the CO 2 incubator for a 1 h recovery period. After an exchange from serum-free, to serum-containing media, the cells were cultured for an additional 5 h. Finally, cells were ®xed as described previously (Mueller et al., 1992) . Injected IgG was visualized by staining the coverslips with secondary Texas Red goat anti-rabbit IgG (Jackson Laboratories).
Microinjected cells were identi®ed using a Zeiss Photoscope II equipped with a 636 Neo¯uor 1.4 Zeiss lens. Injected cells were identi®ed as positive by the presence of DAPI stained nuclei and cytosolic IgG immunolabeling. Coverslips were analysed blind, and individual cells were classi®ed as invasive if a cluster of at least four holes in the FITC-gelatin matrix was present underneath the cell body. 20 ± 50 non-microinjected cells and 20 ± 50 microinjected cells were counted per coverslip. The data are presented as a percentage of invasive cells relative to total cells and the mean and standard error were calculated from three experiments carried out on separate days.
Cell fractionation and Western blotting
MDA-MB-231 cells were cultured at 5610 6 cells/30 cm diameter plate on crosslinked gelatin ®lms for 6, 24 or 48 h, according to a previously described protocol (Mueller et al., 1992) . At 6 and 24 h cells were 60 ± 70% con¯uent. At 48 h post plating, cells were con¯uent. At each time point cell bodies were sheared from the surface of the plates to leave an invadopodia-enriched fraction embedded in the gelatin. The cell body fraction was further separated into the cell body membranes and cytosol fractions (Mueller et al., 1992) . Brie¯y, each plate was washed in TBS and rinsed in tyrosine phosphorylated protein (YPP) buer (10 mM MOPS, pH 6.8, 100 mM KCl, 2.5 mM MgCl 2 , 1 mM CaCl 2 , 0.3 M sucrose, 1 mM vanadate, 2 mM PMSF, 2 mg/ml leupeptin, 2 mg/ml aprotinin and 0.02% NaN 3 ). Cell bodies were sheared with a glass rod into a small volume of YPP buer. CBM were separated from the CYT by centrifugation at 9000 g for 20 min at 48C. The invadopodial membranes, embedded in the gelatin matrix, were rinsed in YPP buer before being scraped up with the crosslinked gelatin into immunoprecipitation buer (50 mM Tris, pH 8.0, 50 mM NaCl, 0.005% deoxycholate, 1% NP40, 1 mM vanadate, 50 mM NaF, 2 mM PMSF, 2 mg/ml leupeptin, 2 mg/ml aprotinin). Each fraction was solubilized in immunoprecipitation buer at 48C for 20 min and samples were taken for protein determination (bicinchoninic acid assay, Pierce). For immunoprecipitation experiments 500 mg of each fraction was incubated with 2 mg of either anti-cortactin or anti-paxillin mAbs for 2 h at 48C. A 15 ml suspension of Protein A-Sepharose beads (Boehringer Mannheim, Indianapolis, IN, USA) was incubated with 2 mg unlabeled anity-puri®ed rabbit anti-mouse IgG+IgM for 2 h at 48C. After the preincubation period, beads were added to the lysate and primary antibody mixture, and incubated overnight at 48C. Beads were washed six times in immunoprecipitation buer and proteins eluted from the beads by boiling in SDS ± PAGE sample buer under reducing conditions. Protein immuno-complexes were separated by SDS ± PAGE in 6% gels and analysed by Western blot analysis.
To characterize the invadopodia fraction morphologically, representative plates were also processed for immunofluorescence. After shearing, and a brief wash in YPP buer, gelatin plates and their embedded invadopodia were ®xed according to the described protocol for immuno¯uorescence. The plates were stained with either Texas-Red phalloidin to visualize Factin, or anti-vinculin antibodies to visualize focal adhesions. Finally, the plates were¯ooded with PBS and examined using a Zeiss 406 water immersion lens.
For total protein lysates, cells were grown in tissue culturē asks to 70 ± 80% con¯uency, washed in ice-cold TBS (150 mM NaCl, 50 mM Tris/HCl, 50 mM Tris pH 7.5) and suspended in 4 ml of immunoprecipitation buer. Cells were solubilized for 15 min at 48C and samples taken for protein determination. Five hundred mg of total protein lysate was used in immunoprecipitation experiments as described above. Also Western blots of lysate and cell fractions were run using 10 mg of protein per lane.
Immuno¯uorescence microscopy
MDA-MB-231 cells were cultured on crosslinked gelatin or FITC-labeled, crosslinked gelatin ®lms overnight as previously described (Mueller et al., 1992) . Cells (7610 4 per 18 mm gelatin coated coverslip) were incubated overnight at 378C, then ®xed and labeled by indirect immuno¯uorescence as previously described (Mueller et al., 1992) . To assist in the visualization of invadopodia, cell bodies were mechanically sheared from the surface of the gelatin, after the cells had been ®xed, using a glass rod. Indirect immuno¯uorescence was performed using a range of mAbs and immunostaining was visualized using anity-puri®ed Texas red goat antimouse antibodies. All primary antibodies were used at 1 : 50 ± 1 : 300 dilution in PBS and all secondary antibody incubations were at a 1 : 200 dilution in PBS. Actin was localized using FITC labeled phalloidin (Molecular Probes, Inc., Eugene, OR, USA) at a dilution of 1 : 400. Nuclei were stained with 4,6-diamidino-2-phenylindole (DAPI) at a ®nal concentration of 80 ng/ml. Coverslips were mounted using the ProLong antifade kit (Molecular Probes, Inc.). Conventional immuno¯uorescence images were digitized using Image Pro Plus from Media Cybernetics (Silver Spring, MD, USA) and a Toshiba integrating camera from I-Cube (Crofton, MD, USA). Confocal images were collected on a Zeiss 410 confocal microscope at a resolution of 0.1323 pixels per micron using a 636/1.4 Zeiss immersion lens.
